A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 862-865

  Tanaka, Shinji ^a,b   Shimada, Mitsuo ^a   Shirabe, Ken ^a   Maehara, Shin Ichiro ^a   Harimoto, Norifumi ^a   Tsujita, Eiji ^a   Sugimachi, Keishi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Advanced hepatocellular carcinoma; Biochemical modulation; Intrahepatic arterial chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HUMAN; INFUSION PUMP; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MALE; PORTAL VEIN; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CATHETERS, INDWELLING; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PORTAL VEIN; PROGNOSIS;

EID: 20644461038     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ince N, Wands JR: The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999; 340:798-789.
2. Lee NW, Wong J, Ong GB: The surgical management of primary carcinoma of the liver. World J Surg 1982; 6:66-75.
3. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K: Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy. Hepatology 1991; 14:802-805.
4. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111:720-726.
5. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Yanaga K, Sugimachi K: Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227:80-85.
6. Shimada M, Yamashita Y, Hamatsu T, Rikimaru T, Hasegawa H, Gion T, Shirabe K, Takenaka K, Sugimachi K: Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology 2000; 47:1095-1099.
7. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T, Sugimachi K: Postoperative prophylactic lipodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995; 169:400-405.
8. Ando E, Yamashita F, Tanaka M, Tanikawa K: A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 1997; 79:1890-1896.
9. LoRusso P, Pazdur R, Redman BG, Kinzie J, Vaitkevicius V: Low-dose continuous infusion 5-fluorouracil and cisplatin: Phase II evaluation in advanced colorectal carcinoma. Am J Clin Oncol 1989; 12:486-490.
10. Lokich J, Zipoli T, Greene R, Paul S, Sonnenborn H, Moore C: Protracted low dose cisplatin infusion in advanced colorectal cancer. Cancer Treat Rep 1986; 70:523-524.
11. Ouchi K, Matsubara S, Fukuhara K, Tominaga T, Matsuno S: Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection. Am J Surg 1993; 166:270-273.
12. Kohno H, Nagasue N, Hayashi T, Yamanoi A, Uchida M, Ono T, Yukaya H, Kimura N, Nakamura T: Postoperative adjuvant chemotherapy after radical resection for hepatocellular carcinoma (HCC). Hepatogastroenterology 1996; 43:1405-1409.
13. Ono T, Nagasue N, Kohno H, Hayashi T, Uchida M, Yukaya H, Yamanoi A: Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Semin Oncol 1997; 24(2 Suppl 6):S6-18-S 6-25.
14. Nonami T, Isshiki K, Katoh H, Kishimoto W, Harada A, Nakao A, Takagi H: The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomasm. Ann Surg 1991; 213:222-226.
15. Nakashima K, Kitano S, Kim YI, Aramaki M, Kawano K: Prospective adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma. Hepatogastroenterology 1996; 43:1410-1414.
16. Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, Ono E, Dohi K, Nakanishi T, Kitamoto M, Azuma K, Itoh K, Shimamoto F: Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma. Hepatogastroenterology 1999; 46:1042-1048.
17. Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, Yoshida T: Use of transcatheter arterial infusion of anti-cancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 1999; 46:1083-1088.
18. Ellerby RA, Davis HL, Ansfield FJ, Ramirez G: Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and cis-platinum (II) diaminedichloride (NSC 119875). Cancer 1974; 34:1005-1010.
19. Scanlon KJ, Newman EM, Lu Y, Priest DG: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986; 83:8923-8925.
20. Hidalgo OF, Gonzalez F, Gil A, Campbell W, Barrajon E, Lacave AJ: 120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer. Am J Clin Oncol 1989; 12:397-401.
21. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK, et al: Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989; 7:1407-1417.
22. Shirasaki T, Shimamoto Y, Oshimo H, Saito H, Fukushima M: Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 1993; 32:167-172.
23. Paquet KJ, Kalk JF, Cuan-Orozco F, Siemens F, Koussouris P, Mercado MA: Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced hepatocellular carcinoma. Eur J Surg Oncol 1992; 18:156-161.
24. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, Fujita M, Ishiguro S: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97:965-971.
25. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 1980; 283:139-146.
26. Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M: Factors correlated with portal venous invasion by hepatocellular carcinoma. Cancer 1996; 77:2022-2031.
27. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
28. Imaeda T, Yamawaki Y, Hirota K, Suzuki M, Seki M, Doi H: Tumor thrombus in the branches of the distal portal vein: CT demonstration. J Comput Assist Tomogr 1989; 13:262-268.
29. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.